We are live on ! Find out more
SGA

Sector Gamma AS Portfolio holdings

AUM $423M
1-Year Est. Return 17.56%
This Fund
S&P 500
This Quarter Est. Return
+3.9%
1 Year Est. Return
+17.56%
3 Year Est. Return
+28.73%
5 Year Est. Return
+52.48%
10 Year Est. Return
+238.19%
AUM
$423M
AUM Growth
+$5.68M
Cap. Flow
-$5.63M
Cap. Flow %
-1.33%
Top 10 Hldgs %
61.07%
Holding
37
New
6
Increased
16
Reduced
8
Closed
6

Top Buys

Rank Stock Value
1
HSP
HOSPIRA INC
HSP
+$11.1M
2
LLY icon
Eli Lilly
LLY
+$7.71M
3
COR icon
Cencora
COR
+$6.85M
4
BSX icon
Boston Scientific
BSX
+$6.59M
5
RDY icon
Dr. Reddy's Laboratories
RDY
+$6.15M

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$18.4M
2
WCG
Wellcare Health Plans, Inc.
WCG
+$12.4M
3
ABBV icon
AbbVie
ABBV
+$11.3M
4
VOLC
VOLCANO CORPORATION COM STK
VOLC
+$9.38M
5
UNH icon
UnitedHealth
UNH
+$9.35M

Sector Composition

Rank Sector Weight
1 Healthcare 88.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LLY icon
1
Eli Lilly
LLY
$1.05T
$57M 13.47%
916,147
+129,200
+16% +$7.71M
BAX icon
2
Baxter International
BAX
$11.7B
$39.2M 9.27%
997,454
-75,297
-7% -$3.01M
BSX icon
3
Boston Scientific
BSX
$65.4B
$32.1M 7.61%
2,517,600
+506,800
+25% +$6.59M
EW icon
4
Edwards Lifesciences
EW
$49.4B
$25.8M 6.1%
1,801,800
-79,800
-4% -$1.08M
THOR
5
DELISTED
THORATEC CORPORATION
THOR
$19.5M 4.6%
558,300
+171,000
+44% +$5.7M
RVTY icon
6
Revvity
RVTY
$12.3B
$18.5M 4.38%
395,460
+39,500
+11% +$1.77M
IRWD icon
7
Ironwood Pharmaceuticals
IRWD
$635M
$17.8M 4.2%
1,383,238
+157,011
+13% +$1.71M
TEVA icon
8
Teva Pharmaceuticals
TEVA
$37.3B
$17.5M 4.15%
334,600
-55,400
-14% -$2.83M
DGX icon
9
Quest Diagnostics
DGX
$23.3B
$16.6M 3.93%
283,128
+24,000
+9% +$1.41M
CAH icon
10
Cardinal Health
CAH
$53.5B
$14.2M 3.36%
207,000
+1,300
+0.6% +$88.5K
CBST
11
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
$13.4M 3.18%
192,490
+26,100
+16% +$1.78M
THC icon
12
Tenet Healthcare
THC
$16.8B
$13.1M 3.09%
278,200
+104,200
+60% +$4.71M
ABBV icon
13
AbbVie
ABBV
$450B
$12.9M 3.05%
228,500
-214,900
-48% -$11.3M
ACOR
14
DELISTED
Acorda Therapeutics
ACOR
$12.6M 2.99%
3,122
+1,033
+49% +$4.21M
RMD icon
15
ResMed
RMD
$28.9B
$12.6M 2.99%
249,300
+28,300
+13% +$1.4M
LPNT
16
DELISTED
LifePoint Health, Inc.
LPNT
$12.4M 2.93%
199,700
-3,200
-2% -$188K
HSP
17
DELISTED
HOSPIRA INC
HSP
$12M 2.84%
+233,800
New +$11.1M
PDCO
18
DELISTED
Patterson Companies, Inc.
PDCO
$10.2M 2.42%
258,465
+38,300
+17% +$1.55M
A icon
19
Agilent Technologies
A
$37.1B
$9.6M 2.27%
233,746
-59,834
-20% -$2.4M
BIO icon
20
Bio-Rad Laboratories Class A
BIO
$8.15B
$7.94M 1.88%
66,300
+6,400
+11% +$781K
COR icon
21
Cencora
COR
$59.9B
$7.27M 1.72%
+100,000
New +$6.85M
RDY icon
22
Dr. Reddy's Laboratories
RDY
$10.5B
$6.31M 1.49%
+730,760
New +$6.15M
MDCO
23
DELISTED
Medicines Co
MDCO
$5.35M 1.27%
184,250
+56,700
+44% +$1.51M
BMY icon
24
Bristol-Myers Squibb
BMY
$124B
$5.34M 1.26%
+110,000
New +$5.42M
CTRX
25
DELISTED
CATAMARAN CORP COM STK (CDA)
CTRX
$5.01M 1.19%
113,500
+53,500
+89% +$2.26M
1
2

Similar funds

AFWM
AMJ Financial Wealth Management Leesburg, Virginia $424M AUM 37.24% 1-Year Est. Return
MP
McDonald Partners Cleveland, Ohio $424M AUM 29.07% 1-Year Est. Return
DS
Dalal Street West Lake Hills, Texas $423M AUM 115.19% 1-Year Est. Return
RS
Retirement Solution Redmond, Washington $423M AUM 16.83% 1-Year Est. Return
DF
Dunhill Financial London, United Kingdom $424M AUM 16.79% 1-Year Est. Return
OGM
OnyxPoint Global Management New York $424M AUM 84.95% 1-Year Est. Return
CPIM
Cypress Point Investment Management Mill Valley, California $424M AUM
MPPLM
Midwest Professional Planners Ltd (MPPL) Wausau, Wisconsin $425M AUM 28.89% 1-Year Est. Return

Sector Gamma AS's Q2 2014 Portfolio in Review

As of Q2 2014, Sector Gamma AS held 37 positions worth $423M, up 1.4% from $417M the previous quarter. Its ten largest holdings account for 61% of the portfolio.

Sector Gamma AS's Q2 2014 filing shows 6 new, 16 increased, 8 reduced and 6 closed positions. Its largest new stake was HOSPIRA INC: 233,800 shares worth $12M. The largest sale was Johnson & Johnson, an estimated $18.4M.

By sector, the portfolio is most concentrated in Healthcare at 88% of assets, up from 85% a quarter earlier.

  • Sector Gamma AS's largest Q2 2014 buy was HOSPIRA INC: 233,800 shares worth $12M.
  • Sector Gamma AS added most to Eli Lilly in Q2 2014, an estimated $7.71M increase.
  • Sector Gamma AS's biggest Q2 2014 reduction was AbbVie, cutting an estimated $11.3M.
  • Sector Gamma AS fully exited Johnson & Johnson in Q2 2014, selling an estimated $18.4M.
  • Sector Gamma AS's ten largest holdings make up 61% of its $423M portfolio in Q2 2014.
  • Sector Gamma AS opened 6 new positions and closed 6 in Q2 2014.
  • Sector Gamma AS's portfolio value rose 1.4% quarter-over-quarter to $423M.

Based on Sector Gamma AS's 13F filing for Q2 2014, filed 15 Aug 2014.